Fulgent Genetics (FLGT) Stock Price, Quote, News & History

Comments

Fulgent Genetics Inc (FLGT) Stock Price, Quote, News & History

FLGTNASDAQ

Trade with Public

$15.59

-0.78-4.76%

At close: Mar 27, 5:00 PM EST

$15.59

N/A

After Hours: 4:34 PM EST

OverviewNews Earnings Options Guidance Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$16.25

Close

$15.59

Volume / Avg.

599.28K / 469.63K

Day Range

$15.44 - $16.25

52 Wk Range

13.46 - 31.04

Market Cap

$481.92M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

37

Short Interest

12.56%

Days to Cover

2.19

Recent Fulgent Genetics Inc News

Why Is Fulgent Genetics Stock Moving Higher Today?

Fulgent Genetics Inc (NASDAQ: FLGT) reported Q2 sales of $68 million, beating the consensus estimate of $62.68 million.<

Vandana Singh

Why Fulgent Genetics Shares Are Trading Higher Today

Vandana Singh

The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company

Here's a roundup of top developments in the biotech space over the last 24 hours:

Shanthi Rexaline

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-101.64M

Investing Cash Flow (TTM)

111.37M

Financing Cash Flow (TTM)

-14.79M

Free Cash Flow (TTM)

-124.21M

Capital Expenditure (TTM)

-22.57M

Net Change in Cash (TTM)

-5.06M

Analyst Trends and Forecast

1

Nov 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$182.85M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

1.56

PB Ratio (TTM)

0.46

Earnings Yield % (TTM)

-12.03%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$35.61

Company Debt

Total Debt

$2.43M

LT Debt

$1.96M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$399.00K

Total Cash

$50.19M

Debt to Equity

0.01

Issuance of Debt (TTM)

-$399.00K

Repayment of Debt (TTM)

-$870.00K

Key Statistics

Open

$16.25

Close

$15.59

Volume / Avg.

599.28K / 469.63K

Day Range

$15.44 - $16.25

52 Wk Range

13.46 - 31.04

Market Cap

$481.92M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

37

Short Interest

12.56%

Days to Cover

2.19

About

Sector

Health Care

Industry

Health Care Providers & Services

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business....

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Fulgent Genetics (FLGT) stock?

A

You can purchase shares of Fulgent Genetics (NASDAQ:FLGT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Fulgent Genetics (FLGT) competitors?

A

Other companies in Fulgent Genetics’s space includes: Prenetics Global Ltd (NASDAQ:PRE), Cross Country Healthcare Inc (NASDAQ:CCRN), OPKO Health Inc (NASDAQ:OPK), Talkspace Inc (NASDAQ:TALK) and Nano X Imaging Ltd (NASDAQ:NNOX).

Q

What is the forecast, or price target, for Fulgent Genetics (FLGT) stock?

A

Fulgent Genetics has a consensus price target of $30.00.

Q

What is the current price for Fulgent Genetics (FLGT)?

A

The stock price for Fulgent Genetics (NASDAQ: FLGT) is $15.59 last updated March 27, 2026 at 4:34 PM EDT.

Q

Does Fulgent Genetics (FLGT) pay a dividend?

A

There are no upcoming dividends for Fulgent Genetics.

Q

When is Fulgent Genetics (NASDAQ:FLGT) reporting earnings?

A

Fulgent Genetics does not have any upcoming earnings scheduled.

Q

Is Fulgent Genetics (FLGT) going to split?

A

There is no upcoming split for Fulgent Genetics.

Q

What sector and industry does Fulgent Genetics (FLGT) operate in?

A

Fulgent Genetics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.

People Also Watch

Cross Country Healthcare Inc

InnovAge Holding Corp

NASDAQ:INNV

$7.65

-3.27%

Park Dental Partners Inc

Key Statistics

Open

$16.25

Close

$15.59

Volume / Avg.

599.28K / 469.63K

Day Range

$15.44 - $16.25

52 Wk Range

13.46 - 31.04

Market Cap

$481.92M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

37

Short Interest

12.56%

Days to Cover

2.19

Recent Fulgent Genetics Inc News

Why Is Fulgent Genetics Stock Moving Higher Today?

Fulgent Genetics Inc (NASDAQ: FLGT) reported Q2 sales of $68 million, beating the consensus estimate of $62.68 million.<

Vandana Singh

Why Fulgent Genetics Shares Are Trading Higher Today

Vandana Singh

The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company

Here's a roundup of top developments in the biotech space over the last 24 hours:

Shanthi Rexaline

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-101.64M

Investing Cash Flow (TTM)

111.37M

Financing Cash Flow (TTM)

-14.79M

Free Cash Flow (TTM)

-124.21M

Capital Expenditure (TTM)

-22.57M

Net Change in Cash (TTM)

-5.06M

Analyst Trends and Forecast

1

Nov 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$182.85M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

1.56

PB Ratio (TTM)

0.46

Earnings Yield % (TTM)

-12.03%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$35.61

Company Debt

Total Debt

$2.43M

LT Debt

$1.96M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$399.00K

Total Cash

$50.19M

Debt to Equity

0.01

Issuance of Debt (TTM)

-$399.00K

Repayment of Debt (TTM)

-$870.00K

Key Statistics

Open

$16.25

Close

$15.59

Volume / Avg.

599.28K / 469.63K

Day Range

$15.44 - $16.25

52 Wk Range

13.46 - 31.04

Market Cap

$481.92M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

37

Short Interest

12.56%

Days to Cover

2.19

About

Sector

Health Care

Industry

Health Care Providers & Services

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business....

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry